Indeed, our rescue experiment shows that pharmacological activation of JNK by anisomycin prohibits the proliferation of MAGEA2-expressing cell and restores its sensitivity to Gem, suggesting that combined anisomycin and Gem can be a novel treatment method to overcome MAGEA-mediated Gem resistance in cancers. This evidence concerns the gene MAGEA2 and cancer.